Piper Sandler raised the firm’s price target on Labcorp (LH) to $260 from $240 following quarterly results. The firm keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp’s Earnings Call Highlights Growth and Optimism
- Labcorp price target raised to $248 from $231 at Deutsche Bank
- Robust Financial Performance and Positive Outlook Support Buy Rating for Labcorp Holdings
- Labcorp price target raised to $293 from $291 at Baird
- Labcorp price target raised to $282 from $271 at BofA